Stocks and Investing
Stocks and Investing
Fri, February 10, 2023
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
Pito Chickering Maintained (THC) at Strong Buy with Increased Target to $65 on, Feb 10th, 2023
Pito Chickering of Deutsche Bank, Maintained "Tenet Healthcare Corporation" (THC) at Strong Buy with Increased Target from $48 to $65 on, Feb 10th, 2023.
Pito has made no other calls on THC in the last 4 months.
There are 6 other peers that have a rating on THC. Out of the 6 peers that are also analyzing THC, 0 agree with Pito's Rating of Hold.
These are the ratings of the 6 analyists that currently disagree with Pito
- Stephen Baxter of "Wells Fargo" Maintained at Buy with Increased Target to $59 on, Tuesday, January 3rd, 2023
- Jamie Perse of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $80 on, Tuesday, November 1st, 2022
- John Ransom of "Raymond James" Maintained at Strong Buy with Decreased Target to $80 on, Thursday, October 27th, 2022
- Jason Cassorla of "Citigroup" Maintained at Strong Buy with Decreased Target to $76 on, Tuesday, October 25th, 2022
- Whit Mayo of "SVB Leerink" Maintained at Buy with Decreased Target to $55 on, Tuesday, October 25th, 2022
- Sarah James of "Barclays" Maintained at Buy with Decreased Target to $67 on, Monday, October 24th, 2022
Contributing Sources